William T. Pappafotopoulos
Directeur Général chez Milton Financial Group
Profil
William T.
Pappafotopoulos is the founder of Milton Financial Group, which was founded in 1985.
He held the title of President & Chief Executive Officer.
Currently, he is a Vice President at Neurovance, Inc. Mr. Pappafotopoulos has an MBA from Suffolk University and an undergraduate degree from Salem State University.
Postes actifs de William T. Pappafotopoulos
| Sociétés | Poste | Début |
|---|---|---|
Milton Financial Group
 Milton Financial Group Miscellaneous Commercial ServicesCommercial Services Milton Financial Group is an accounting, finance, tax, and business management firm. The private company is based in Braintree, MA. The company was founded by William T. Pappafotopoulos. William T. Pappafotopoulos has been the CEO since incorporation. | Directeur Général | 01/01/1985 |
Neurovance, Inc.
 Neurovance, Inc. Miscellaneous Commercial ServicesCommercial Services Neurovance, Inc. operates as a a biopharmaceutical company. It develops treatments for central nervous system disorders. The company was founded by Anthony McKinney and Franklin P. Bymaster in 2011 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - |
Anciens postes connus de William T. Pappafotopoulos
| Sociétés | Poste | Fin |
|---|---|---|
| Internal Revenue Service | Corporate Officer/Principal | - |
| JOHNSON & JOHNSON | Comptroller/Controller/Auditor | - |
Raytheon Aerospace Co.
 Raytheon Aerospace Co. Aerospace & DefenseElectronic Technology Part of AIP LLC, Raytheon Aerospace Co. is a company that manufactures aerospace equipment. The company is based in Madison, MS. Raytheon Aerospace was acquired by The Veritas Capital Fund LP from Raytheon Co. on June 28, 2001 for $157 million. | Comptroller/Controller/Auditor | - |
Euthymics Bioscience, Inc.
 Euthymics Bioscience, Inc. Miscellaneous Commercial ServicesCommercial Services Euthymics Bioscience, Inc. develops a novel medicine for alcohol use disorder (AUD) and smoking cessation. It engages in developing a medicine for central nervous system disorders of significant unmet medical need, including major depressive disorder (MDD) and alcohol use disorder (AUD). The firm provides Amitifadine, an antidepressant for major depressive disorder. The firm focuses on the modulation of neurotransmitters, including serotonin (5-HT), norepinephrine (NE), and dopamine (DA). The company was founded by Anthony A. McKinney and Franklin P. Bymaster in 2009 and is headquartered in Cambridge, MA. | Directeur Financier/CFO | - |
Formation de William T. Pappafotopoulos
| Suffolk University | Masters Business Admin |
| Salem State University | Undergraduate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| JOHNSON & JOHNSON | Health Technology |
| Entreprise privées | 5 |
|---|---|
Neurovance, Inc.
Neurovance, Inc. Miscellaneous Commercial ServicesCommercial Services Neurovance, Inc. operates as a a biopharmaceutical company. It develops treatments for central nervous system disorders. The company was founded by Anthony McKinney and Franklin P. Bymaster in 2011 and is headquartered in Cambridge, MA. | Commercial Services |
Raytheon Aerospace Co.
Raytheon Aerospace Co. Aerospace & DefenseElectronic Technology Part of AIP LLC, Raytheon Aerospace Co. is a company that manufactures aerospace equipment. The company is based in Madison, MS. Raytheon Aerospace was acquired by The Veritas Capital Fund LP from Raytheon Co. on June 28, 2001 for $157 million. | Electronic Technology |
| Internal Revenue Service | Government |
Euthymics Bioscience, Inc.
Euthymics Bioscience, Inc. Miscellaneous Commercial ServicesCommercial Services Euthymics Bioscience, Inc. develops a novel medicine for alcohol use disorder (AUD) and smoking cessation. It engages in developing a medicine for central nervous system disorders of significant unmet medical need, including major depressive disorder (MDD) and alcohol use disorder (AUD). The firm provides Amitifadine, an antidepressant for major depressive disorder. The firm focuses on the modulation of neurotransmitters, including serotonin (5-HT), norepinephrine (NE), and dopamine (DA). The company was founded by Anthony A. McKinney and Franklin P. Bymaster in 2009 and is headquartered in Cambridge, MA. | Commercial Services |
Milton Financial Group
Milton Financial Group Miscellaneous Commercial ServicesCommercial Services Milton Financial Group is an accounting, finance, tax, and business management firm. The private company is based in Braintree, MA. The company was founded by William T. Pappafotopoulos. William T. Pappafotopoulos has been the CEO since incorporation. | Commercial Services |